Intended for healthcare professionals


Infographic - Patient and public partnership

Patient and public partnership

In June 2014The BMJ launched a new strategy to promote patient partnership. It took this step because it sees partnering with patients, their families, carers, advocacy groups, and the public as an ethical imperative, which is essential to improving the quality, safety, cost effectiveness, and sustainability of healthcare. The strategy brings landmark changes to The BMJ’s internal processes. It was “co –produced” with the members of its new international patient advisory panel, which was set up to help steer the implementation of the strategy.

Better evidence

The BMJ believes that the design, conduct, and reporting of healthcare research should better serve the needs of patients and the public: better evidence leads to better healthcare.

Latest campaigns

Wellbeing campaign

The BMJ has long championed the wellbeing of doctors, both for their own sake and the sake of their patients. We have pulled together an online collection of articles published in the past few years, including recent articles on the importance of staff engagement, how to deal with a bullying colleague and optimising sleep for night shifts. Future articles will look at the issues affecting doctors’ physical and psychological health, both in and outside of work.

Climate change

Climate change

In October 2014 The BMJ called on the World Health Organization (WHO) to declare a public health emergency on climate change. Putting climate change at the top of the list of things to worry about is hard when faced with the daily challenges of clinical care, but it poses a greater risk to human health than either communicable of non-communicable disease.

Open data campaign logo

Open Data

Hidden clinical trial data are systematically undermining doctors’ abilities to prescribe treatment with confidence. A whole range of widely used drugs across all fields of medicine have been represented as safer and more effective than they are, endangering people’s lives and wasting public money. As of January 2013, the BMJ will no longer publish any trial of drugs or devices where the authors do not commit to making the relevant anonymised patient level data available, upon reasonable request.